Back
Virtus LifeSci Biotech Clinical Trials ETF Vs. SMX (Security Matters) Plc Industry Stock Comparison
Buy
76
BBC
Virtus LifeSci Biotech Clinical Trials ETF
Last Price:
$40.21
Seasonality Move:
-0.67%
Sell
50
SMX
SMX (Security Matters) Plc
Last Price:
$181.82
Seasonality Move:
-23.68%
Buy
76
Virtus LifeSci Biotech Clinical Trials ETF (BBC)
is a Buy
Is Virtus LifeSci Biotech Clinical Trials ETF a Buy, Sell or Hold?
-
The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $39.95. The Score for BBC is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
BBC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
SMX (Security Matters) Plc (SMX)
is a Sell
Is SMX (Security Matters) Plc a Buy, Sell or Hold?
-
The current SMX (Security Matters) Plc [SMX] share price is $181.71. The Score for SMX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BBC Stock Price Chart
What is Virtus LifeSci Biotech Clinical Trials ETF's stock price today?
-
The Virtus LifeSci Biotech Clinical Trials ETF share price today is $39.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBC is experiencing slight selling pressure.
SMX Stock Price Chart
What is SMX (Security Matters) Plc's stock price today?
-
The SMX (Security Matters) Plc share price today is $181.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMX is experiencing selling pressure, which indicates risk of future bearish movement.
BBC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.21 | Buy |
| Relative Strength Index (14 RSI): | 70.76 | Buy |
| Chaikin Money Flow: | -9953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.46 - 38.8) | Buy |
| Bollinger Bands (100): | (22.65 - 33.71) | Buy |
SMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 37.97 | Buy |
| Relative Strength Index (14 RSI): | 59.03 | Buy |
| Chaikin Money Flow: | -322270 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-18.22 - 149.2) | Buy |
| Bollinger Bands (100): | (-55.65 - 488.63) | Sell |
BBC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.18 | Buy |
| 20-day SMA: | 36.73 | Buy |
| 50-day SMA: | 32.94 | Buy |
| 200-day SMA: | 23.56 | Buy |
| 8-day EMA: | 39.08 | Buy |
| 20-day EMA: | 37 | Buy |
| 50-day EMA: | 33.37 | Buy |
| 200-day EMA: | 26.72 | Buy |
SMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.3 | Buy |
| 20-day SMA: | 78.61 | Buy |
| 50-day SMA: | 68.21 | Buy |
| 200-day SMA: | 1977.31 | Sell |
| 8-day EMA: | 157.45 | Buy |
| 20-day EMA: | 107.82 | Buy |
| 50-day EMA: | 145.98 | Buy |
| 200-day EMA: | 843678.42 | Sell |
Virtus LifeSci Biotech Clinical Trials ETF Earnings Growth & BBC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SMX (Security Matters) Plc Earnings Growth & SMX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Clinical Trials ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SMX (Security Matters) Plc Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||